Search research articles
Contact Us
Filters
Showing results (71-80 of 110) with videos related to
Page
of 11
Sort By:
Hepatology (Baltimore, Md.)
|
August 1, 1993
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy
A Tran, J F Quaranta, S Benzaken, et al.
Presse Medicale (Paris, France : 1983)
|
April 8, 1995
[Persistent diarrhea in HIV infected patients: role of Enterocytozoon bieneusi]
E Bernard, M Carles, C Pradier, et al.
AIDS (London, England)
|
December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients
A N Phillips, C Pradier, A Lazzarin, et al.
AIDS (London, England)
|
June 17, 1999
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group
A Mocroft, O Kirk, S E Barton, et al.
AIDS Care
|
September 9, 2010
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial
L Bentz, P Enel, B Dunais, et al.
Presse Medicale (Paris, France : 1983)
|
December 24, 1997
[Malaria attacks after returning from endemic areas. Failure or inadequate chemoprophylaxis?]
P Pugliese, S Martini-Wehrlen, P M Roger, et al.
AIDS (London, England)
|
June 16, 2001
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir
O Kirk, A Mocroft, C Pradier, et al.
European Journal of Gastroenterology & Hepatology
|
September 28, 2000
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease
A Tran, S Benzaken, M C Saint-Paul, et al.
International Journal of Cancer
|
July 10, 1999
Risk of invasive cervical cancer among women with, or at risk for, HIV infection
D Serraino, P Carrieri, C Pradier, et al.
Presse Medicale (Paris, France : 1983)
|
October 13, 1998
[Lung cancer in patients infected with human immunodeficiency virus. Clinical course and therapeutic implications]
F Peyrade, B Taillan, C Pradier, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 110) with videos related to
Sort By:
Page
of 11
Hepatology (Baltimore, Md.)
|
August 1, 1993
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy
A Tran, J F Quaranta, S Benzaken, et al.
Presse Medicale (Paris, France : 1983)
|
April 8, 1995
[Persistent diarrhea in HIV infected patients: role of Enterocytozoon bieneusi]
E Bernard, M Carles, C Pradier, et al.
AIDS (London, England)
|
December 12, 2001
Viral load outcome of non-nucleoside reverse transcriptase inhibitor regimens for 2203 mainly antiretroviral-experienced patients
A N Phillips, C Pradier, A Lazzarin, et al.
AIDS (London, England)
|
June 17, 1999
Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group
A Mocroft, O Kirk, S E Barton, et al.
AIDS Care
|
September 9, 2010
Evaluating counseling outcome on adherence to prophylaxis and follow-up after sexual HIV-risk exposure: a randomized controlled trial
L Bentz, P Enel, B Dunais, et al.
Presse Medicale (Paris, France : 1983)
|
December 24, 1997
[Malaria attacks after returning from endemic areas. Failure or inadequate chemoprophylaxis?]
P Pugliese, S Martini-Wehrlen, P M Roger, et al.
AIDS (London, England)
|
June 16, 2001
Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir
O Kirk, A Mocroft, C Pradier, et al.
European Journal of Gastroenterology & Hepatology
|
September 28, 2000
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease
A Tran, S Benzaken, M C Saint-Paul, et al.
International Journal of Cancer
|
July 10, 1999
Risk of invasive cervical cancer among women with, or at risk for, HIV infection
D Serraino, P Carrieri, C Pradier, et al.
Presse Medicale (Paris, France : 1983)
|
October 13, 1998
[Lung cancer in patients infected with human immunodeficiency virus. Clinical course and therapeutic implications]
F Peyrade, B Taillan, C Pradier, et al.
Page
of 11